نتائج البحث - Reshma Rangwala

  • يعرض 1 - 13 نتائج من 13
تنقيح النتائج
  1. 1
    Regulation of Immunoproteasome Subunit Expression In Vivo Following Pathogenic Fungal Infection

    Regulation of Immunoproteasome Subunit Expression In Vivo Following Pathogenic Fungal Infection حسب Lance F. Barton, Miguel Cruz, Reshma Rangwala, George S. Deepe, John J. Monaco

    منشور في 2002
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    195TiP: Pembrolizumab (MK-3475) versus platinum-based chemotherapy for PD-L1+ NSCLC in a phase 3, randomized, open-label study: KEYNOTE-042

    195TiP: Pembrolizumab (MK-3475) versus platinum-based chemotherapy for PD-L1+ NSCLC in a phase 3, randomized, open-label study: KEYNOTE-042 حسب Tony Mok, Yi‐Long Wu, S. Sadowski, J. Zhang, Reshma Rangwala, Debra Kush, Gilberto Lopes

    منشور في 2016
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    P2.43: Pembrolizumab vs Platinum-Based Chemotherapy for PD-L1+ NSCLC: Phase 3, Randomized, Open-Label KEYNOTE-042 (NCT02220894)

    P2.43: Pembrolizumab vs Platinum-Based Chemotherapy for PD-L1+ NSCLC: Phase 3, Randomized, Open-Label KEYNOTE-042 (NCT02220894) حسب Gilberto Lopes, Yi‐Long Wu, S. Sadowski, Jin Zhang, Reshma Rangwala, Debra Kush, Tony Mok

    منشور في 2016
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Prevalence of PD-L1 expression in patients with non-small cell lung cancer screened for enrollment in KEYNOTE-001, -010, and -024

    Prevalence of PD-L1 expression in patients with non-small cell lung cancer screened for enrollment in KEYNOTE-001, -010, and -024 حسب Charu Aggarwal, Delvys Rodríguez‐Abreu, Enriqueta Felip, Enric Carcereny, Maya Gottfried, Thomas Wehler, Myung‐Ju Ahn, Marisa Dolled‐Filhart, J. Zhang, Yue Shentu, Reshma Rangwala, Bilal Piperdi, Paul Baas

    منشور في 2016
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Coordinate control of axon defasciculation and myelination by laminin-2 and -8

    Coordinate control of axon defasciculation and myelination by laminin-2 and -8 حسب Dongren Yang, Jesse Bierman, Yukie S. Tarumi, Yong-Ping Zhong, Reshma Rangwala, Thomas M. Proctor, Yuko Miyagoe‐Suzuki, Shin’ichi Takeda, Jeffrey H. Miner, Larry S. Sherman, Bruce G. Gold, Bruce L. Patton

    منشور في 2005
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer

    Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer حسب Martin Reck, Delvys Rodríguez‐Abreu, Andrew Robinson, Rina Hui, Tibor Csőszi, Andrea Fülöp, Maya Gottfried, Nir Peled, Ali Tafreshi, Sinéad Cuffe, Mary O’Brien, Suman Rao, Katsuyuki Hotta, Melanie A. Leiby, Gregory M. Lubiniecki, Yue Shentu, Reshma Rangwala, Julie R. Brahmer

    منشور في 2016
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Combined autophagy and proteasome inhibition

    Combined autophagy and proteasome inhibition حسب Dan T. Vogl, Edward A. Stadtmauer, Kay-See Tan, Daniel F. Heitjan, Lisa E. Davis, Laura Pontiggia, Reshma Rangwala, Shengfu Piao, Yunyoung C Chang, Emma C. Scott, Thomas Paul, Charles W. Nichols, David Porter, Janeen Kaplan, G. Mallon, James E. Bradner, Ravi K. Amaravadi

    منشور في 2014
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Pembrolizumab as first-line therapy for patients with PD-L1-positive advanced non-small cell lung cancer: a phase 1 trial

    Pembrolizumab as first-line therapy for patients with PD-L1-positive advanced non-small cell lung cancer: a phase 1 trial حسب Rina Hui, Edward B. Garon, J.W. Goldman, Natasha B. Leighl, Matthew D. Hellmann, Amita Patnaik, Leena Gandhi, Joseph P. Eder, Myung‐Ju Ahn, Leora Horn, Enriqueta Felip, Enric Carcereny, Reshma Rangwala, Gregory M. Lubiniecki, J. Zhang, Kenneth Emancipator, Charlotte Roach, Naiyer A. Rizvi

    منشور في 2017
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    Tisotumab vedotin in patients with advanced or metastatic solid tumours (InnovaTV 201): a first-in-human, multicentre, phase 1–2 trial

    Tisotumab vedotin in patients with advanced or metastatic solid tumours (InnovaTV 201): a first-in-human, multicentre, phase 1–2 trial حسب Johann S. de Bono, Nicole Concin, David S. Hong, Fiona Thistlethwaite, Jean-Pascal Machiels, Hendrik‐Tobias Arkenau, Ruth Plummer, Robert H. Jones, Dorte Nielsen, Kristian Windfeld, Srinivas Ghatta, Brian M. Slomovitz, James Spicer, Jeffrey Yachnin, Joo Ern Ang, Morten Mau‐Sørensen, Martin Förster, Dearbhaile Catherine Collins, Emma Dean, Reshma Rangwala, Ulrik Lassen

    منشور في 2019
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    Tisotumab Vedotin in Previously Treated Recurrent or Metastatic Cervical Cancer

    Tisotumab Vedotin in Previously Treated Recurrent or Metastatic Cervical Cancer حسب David S. Hong, Nicole Concin, Ignace Vergote, Johann S. de Bono, Brian M. Slomovitz, Yvette Drew, Hendrik‐Tobias Arkenau, Jean-Pascal Machiels, James Spicer, Robert H. Jones, Martin Förster, Nathalie Cornez, Christine Gennigens, Melissa L. Johnson, Fiona Thistlethwaite, Reshma Rangwala, Srinivas Ghatta, Kristian Windfeld, Jeffrey R. Harris, Ulrik Lassen, Robert L. Coleman

    منشور في 2019
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    Phase I trial of hydroxychloroquine with dose-intense temozolomide in patients with advanced solid tumors and melanoma

    Phase I trial of hydroxychloroquine with dose-intense temozolomide in patients with advanced solid tumors and melanoma حسب Reshma Rangwala, Robert D. Leone, Yunyoung C Chang, Leslie A. Fecher, Lynn M. Schuchter, Amy Kramer, Kay-See Tan, Daniel F. Heitjan, Glenda Rodgers, Maryann Gallagher, Shengfu Piao, Andrea B. Troxel, Tracey L. Evans, Angela DeMichele, Katherine L. Nathanson, Peter J. O’Dwyer, Jonathon Kaiser, Laura Pontiggia, Lisa E. Davis, Ravi K. Amaravadi

    منشور في 2014
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  12. 12
    Combined MTOR and autophagy inhibition

    Combined MTOR and autophagy inhibition حسب Reshma Rangwala, Yunyoung C Chang, Janice Hu, Kenneth M. Algazy, Tracey L. Evans, Leslie A. Fecher, Lynn M. Schuchter, Drew A. Torigian, Jeffrey T Panosian, Andrea B. Troxel, Kay-See Tan, Daniel F. Heitjan, Angela DeMichele, David J. Vaughn, Maryann Redlinger, Abass Alavi, Jonathon Kaiser, Laura Pontiggia, Lisa E. Davis, Peter J. O’Dwyer, Ravi K. Amaravadi

    منشور في 2014
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  13. 13
    Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer

    Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer حسب Edward B. Garon, Naiyer A. Rizvi, Rina Hui, Natasha B. Leighl, Ani Sarkis Balmanoukian, Joseph P. Eder, Amita Patnaik, Charu Aggarwal, Matthew A. Gubens, Leora Horn, Enric Carcereny, Myung‐Ju Ahn, Enriqueta Felip, Jong-Seok Lee, Matthew D. Hellmann, Omid Hamid, Jonathan W. Goldman, Jean‐Charles Soria, Marisa Dolled‐Filhart, Ruth Z. Rutledge, Jin Zhang, Jared Lunceford, Reshma Rangwala, Gregory M. Lubiniecki, Charlotte Roach, Kenneth Emancipator, Leena Gandhi

    منشور في 2015
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: